Biological significance of promoter hypermethylation of tumor-related genes in patients with gastric carcinoma

Clinica Chimica Acta

Volumn 404, Issue 2, 2009, Pages 128-133

  Ksiaa, Feryel ^a   Ziadi, Sonia ^a   Amara, Khaled ^a   Korbi, Sadok ^a   Trimeche, Mounir ^a  

^a Farhat Hached hospital Sousse   (Tunisia)

Author keywords

Gastric cancer; Hypermethylation; Tumor suppressor genes

Indexed keywords

ADULT; AGED; APC GENE; ARTICLE; CANCER TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; DAPK GENE; DNA METHYLATION; EPIGENETICS; EPSTEIN BARR VIRUS; FEMALE; GENE; GENE FREQUENCY; GENE LOCATION; GSTP1 GENE; HMLH1 GENE; HUMAN; HUMAN TISSUE; INTESTINE; MAJOR CLINICAL STUDY; MALE; MGMT GENE; P14 GENE; P16 GENE; PATHOGENESIS; PATHOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; RAR BETA2 GENE; RASSFIA GENE; SHP1 GENE; STOMACH CARCINOMA; TIMP3 GENE; TUMOR SUPPRESSOR GENE; TUNISIA; VIRUS INFECTION;

AGED; CARCINOMA; CPG ISLANDS; DNA METHYLATION; FEMALE; GENES; GENES, NEOPLASM; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROMOTER REGIONS, GENETIC; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

HUMAN HERPESVIRUS 4;

EID: 67349124873     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.03.044     Document Type: Article

References (35)

1. Jemal A., Tiwari R.C., Murray T., et al. Cancer statistics, 2004. CA: a cancer journal for clinicians vol. 54 (2004) 8-29
2. McCulloch P., Ward J., and Tekkis P.P. Mortality and morbidity in gastro-oesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort study. BMJ Clin Res Ed 327 (2003) 1192-1197
3. Wu C.W., Chi C.W., and Lin W.C. Gastric cancer: prognostic and diagnostic advances. Exp Rev Mol Med 4 (2002) 1-12
4. Nardone G., and Morgner A. Helicobacter pylori and gastric malignancies. Helicobacter 8 Suppl 1 (2003) 44-52
5. Shibata D., and Weiss L.M. Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol 140 (1992) 769-774
6. Tamura G. Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. W J Gastroenterol 12 (2006) 192-198
7. Kim T.Y., Jong H.S., Jung Y., Kim T.Y., Kang G.H., and Bang Y.J. DNA hypermethylation in gastric cancer. Aliment Pharmacol Ther 20 Suppl 1 (2004) 131-142
8. Esteller M. Aberrant DNA methylation as a cancer-inducing mechanism. Ann Rev Pharmacol Toxicol 45 (2005) 629-656
9. Kang G.H., Shim Y.H., Jung H.Y., Kim W.H., Ro J.Y., and Rhyu M.G. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res 61 (2001) 2847-2851
10. Kang G.H., Lee S., Kim J.S., and Jung H.Y. Profile of aberrant CpG island methylation along multistep gastric carcinogenesis. Lab Invest 83 (2003) 519-526
11. Toyota M., Ahuja N., Suzuki H., et al. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res 59 (1999) 5438-5442
12. Kusano M., Toyota M., Suzuki H., et al. Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus. Cancer 106 (2006) 1467-1479
13. An C., Choi I.S., Yao J.C., et al. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma. Clin Cancer Res 11 (2005) 656-663
14. Kang G.H., Lee S., Kim W.H., et al. Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am J Pathol 160 (2002) 787-794
15. Toyota M., Ahuja N., Ohe-Toyota M., Herman J.G., Baylin S.B., and Issa J.P. CpG island methylator phenotype in colorectal cancer. PNAS 96 (1999) 8681-8686
16. Brock M.V., Gou M., Akiyama Y., et al. Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma. Clin Cancer Res 9 (2003) 2912-2919
17. Shaw R.J., Hall G.L., Lowe D., et al. CpG island methylation phenotype (CIMP) in oral cancer: associated with a marked inflammatory response and less aggressive tumour biology. Oral oncology 43 (2007) 878-886
18. Sobin L.H., and Fleming I.D. TNM classification of malignant tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 80 (1997) 1803-1804
19. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64 (1965) 31-49
20. Man Y.G., Moinfar F., Bratthauer G.L., Kuhls E.A., and Tavassoli F.A. An improved method for DNA extraction from paraffin sections. Pathol Res Pract 197 (2001) 635-642
21. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., and Baylin S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. PNAS 93 (1996) 9821-9826
22. Amara K., Trimeche M., Ziadi S., et al. Presence of simian virus 40 DNA sequences in diffuse large B-cell lymphomas in Tunisia correlates with aberrant promoter hypermethylation of multiple tumor suppressor genes. Int J Cancer 121 (2007) 2693-2702
23. Ye M., Xia B., Guo Q., Zhou F., and Zhang X. Association of diminished expression of RASSFIA with promoter methylation in primary gastric cancer from patients of central China. BMC cancer 7 (2007) 120
24. Herman J.G., Merlo A., Mao L., et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55 (1995) 4525-4530
25. Oue N., Oshimo Y., Nakayama H., et al. DNA methylation of multiple genes in gastric carcinoma: association with histological type and CpG island methylator phenotype. Cancer Sci 94 (2003) 901-905
26. Hou P., Ji M.J., Shen J.Y., He N.Y., and Lu Z.H. Detection of p16 hypermethylation in gastric carcinomas using a semi nested methylation-specific PCR. Biochem Gen 43 (2005) 1-9
27. Luo D., Zhang B., Lv L., et al. Methylation of CpG islands of p16 associated with progression of primary gastric carcinomas. Lab Invest 86 (2006) 591-598
28. Oue N., Motoshita J., Yokozaki H., et al. Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas. J Pathol 198 (2002) 55-59
29. Leung W.K., To K.F., Chu E.S., et al. Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer. Brit J Cancer 92 (2005) 2190-2194
30. Leung W.K., Yu J., Ng E.K., et al. Concurrent hypermethylation of multiple tumor-related genes in gastric carcinoma and adjacent normal tissues. Cancer 91 (2001) 2294-2301
31. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, liver flukes and Helicobacter pylori. Lyon, 7-14 June 1994. IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, IARC press, 1994, 61:1-241.
32. Maekita T., Nakazawa K., Mihara M., et al. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 12 (2006) 989-995
33. Chan A.O., Lam S.K., Wong B.C., et al. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 52 (2003) 502-506
34. Chang M.S., Uozaki H., Chong J.M., Ushiku T., Sakuma K., Ishikawa S., et al. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus. Clin Cancer Res 12 (2006) 2995-3002
35. Chong J.M., Sakuma K., Sudo M., et al. Global and non-random CpG-island methylation in gastric carcinoma associated with Epstein-Barr virus. Cancer Sci 94 (2003) 76-80